We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6
Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection
โ Scribed by Max Hopwood; Carla Treloar
- Book ID
- 108833378
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 63 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0309-2402
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complet
## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCVโ4 responds poorly to interferon. Pegylated